Clinical Trials Browser

Phase 2 × OTHER × Cystadenocarcinoma, Serous × Clear all

NCT04575961 2025-05-23

PERCEPTION

Phase 2 Active not recruiting

Fallopian Tube Neoplasms, Ovarian Neoplasms, Cystadenocarcinoma, Serous

NCT04716686 2024-01-05

Niraparib Monotherapy as Maintain and Recurrent Treatment of Endometrial Serous Carcinoma

Phase 2 Recruiting

Endometrial Neoplasms, Cystadenocarcinoma, Serous

NCT00515073 2014-07-03

Papillary Serous Carcinoma of the Endometrium

Phase 2 Completed

30 enrolled 5 charts

Endometrial Neoplasms, Cystadenocarcinoma, Serous